Preferred Label : Bevacizumab/Carboplatin/Liposomal Doxorubicin Regimen;
NCIt synonyms : Liposomal Doxorubicin/Carboplatin/Bevacizumab; Liposomal Doxorubicin/Bevacizumab/Carboplatin Regimen; Bevacizumab/Carboplatin/Pegylated Liposomal Doxorubicin; Avastin/Carboplatin/Doxil; Carboplatin/Liposomal Doxorubicin/Bevacizumab;
NCIt related terms : Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab; Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab-adcd; Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab-awwb; Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab-bvzr; Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab-equi; Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab-aybi; Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab-maly; Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab-onbe;
NCIt definition : A regimen consisting of bevacizumab, carboplatin and liposomal doxorubicin that can
be used for the treatment of ovarian, fallopian tube and primary peritoneal cancer.;
NCI Metathesaurus CUI : CL1912821;
Codes from synonyms : 5704; 127201; 127423; 127645; 127349; 127571; 127275; 127497;
Origin ID : C192824;
UMLS CUI : C5785445;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
